Chronic Plaque Psoriasis is a chronic inflammatory skin disease characterized by well-demarcated, erythematous, scaly plaques on the extensor surfaces of the body and scalp. Some of the key Chronic Plaque Psoriasis symptoms include red patches of skin covered with thick, silvery scales, small scaling spots, dry, cracked skin, itching, burning or soreness, thickened, pitted or ridged nails, swollen and stiff joints. The major risk factors for Chronic Plaque Psoriasis include family history, stress, and smoking. <a href="https://www.delveinsight.com/report-store/chronic-plaque-psoriasis-epidemiology-forecast" rel="noopener noreferrer" target="_blank" style="background-color: transparent; color: rgb(17, 85, 204);">Chronic Plaque Psoriasis Epidemiology</a> Segmentation in the 7MM for the Study Period 2018-30<ul><li class="ql-align-justify">Prevalence of Psoriasis (Adults and Pediatrics)</li><li class="ql-align-justify">Chronic Plaque Psoriasis Prevalence&nbsp;&nbsp;</li><li class="ql-align-justify">Prevalence of Chronic Plaque Psoriasis by Severity</li><li class="ql-align-justify">Diagnosed and Treatable Cases of Chronic Plaque Psoriasis</li></ul> Chronic Plaque Psoriasis Epidemiology Insights Observed in 2020<ul><li class="ql-align-justify">The total prevalent population of psoriasis in 7MM was found to be 15,450,712.</li><li class="ql-align-justify">The prevalent cases of plaque psoriasis in the United States were observed to be 6.6 Million.</li><li class="ql-align-justify">In the US, 5.3 million cases of mild to moderate chronic plaque psoriasis and 1.3 million cases of moderate-to-severe chronic plaque psoriasis were reported in 2020.</li></ul> <a href="https://www.delveinsight.com/report-store/chronic-plaque-psoriasis-market" rel="noopener noreferrer" target="_blank" style="background-color: transparent; color: rgb(17, 85, 204);">Chronic Plaque Psoriasis Market Insight</a>The Chronic Plaque Psoriasis Market is expected to grow at a CAGR of 5% in 7MM for the study period 2021–2030. <a href="https://www.delveinsight.com/report-store/chronic-plaque-psoriasis-pipeline-insight" rel="noopener noreferrer" target="_blank" style="background-color: transparent; color: rgb(17, 85, 204);">Chronic Plaque Psoriasis Emerging Therapies</a>The emerging drugs in the Chronic Plaque Psoriasis market are<ul><li class="ql-align-justify">Tapinarof (DVMT-505)</li><li class="ql-align-justify">PF-06826647</li><li class="ql-align-justify">ARQ-151</li><li class="ql-align-justify">Deucravacitinib (BMS-986165)</li><li class="ql-align-justify">Sonelokimab</li><li class="ql-align-justify">Bimekizumab (UCB4940)</li><li class="ql-align-justify">PPC-06</li><li class="ql-align-justify">KD025 (SLx-2119)</li><li class="ql-align-justify">PF-06700841 (Brepocitinib)</li><li class="ql-align-justify">BI 730357</li><li class="ql-align-justify">JTE-451</li><li class="ql-align-justify">ABY-035</li></ul>And several others. Chronic Plaque Psoriasis Market Prominent PlayersThe key companies in the Chronic Plaque Psoriasis market are<ul><li class="ql-align-justify">Dermavant Sciences</li><li class="ql-align-justify">Pfizer</li><li class="ql-align-justify">Arcutis Biotherapeutics</li><li class="ql-align-justify">BMS</li><li class="ql-align-justify">Merck</li><li class="ql-align-justify">UCB Pharma</li><li class="ql-align-justify">Arbor Pharmaceuticals/Dr. Reddy’s Laboratories</li><li class="ql-align-justify">Kadmon Pharmaceuticals</li><li class="ql-align-justify">Pfizer</li><li class="ql-align-justify">Boehringer Ingelheim</li><li class="ql-align-justify">Akros Pharma</li><li class="ql-align-justify">Affibody AB</li></ul>And several others.

Chronic Plaque Psoriasis Market Infographic

Chronic Plaque Psoriasis Market

Chronic Plaque Psoriasis Market Size and Share Infographic

Chronic Plaque Psoriasis Market Infographic provides insights into the Market Size, Trends, Treatment, Epidemiology, Companies, and Emerging Therapies